Health and Pharmaceuticals

Orion Health confirms float details

by AAP
Global healthcare software solutions provider looking to raise up to $NZ150m through NZ, Aust floats.

Medibank IPO to raise up to $5.508bn

Prospectus shows Medibank shares priced in range between $1.55-$2 per share.

CSL enlisted in hunt for Ebola treatment

Australian firm acts on request from the Gates Foundation to develop plasma product in fight against Ebola.

Abbvie ditches Shire takeover

by AFP
US pharma giant U-turns on $54bn takeover after tax law tightens.

Choppy seas ahead for the Medibank float

Volatility in the market may have increased, but analysts say there is still an appetite among investors for new listings.

Antara Lifesciences slumps on debut

by AAP
Biotech firm in hunt for diarrhoea cure loses 26% on ASX debut.

Ansell organic sales growth up 3% in Q1

Gloves and condom manufacturer reaffirms share earnings guidance, increases sales growth.

Medibank float gets strong pre-registration interest

Interest in health insurer’s $4 billion-plus IPO exceeds government expectations.

AbbVie wavers on Shire takeover

by AFP
US drugmaker reconsidering $US54 billion deal in light of US tax inversion crackdowns.

CSL announces $950m buyback

Global biotech manufacturer says it will buy back $950m of shares, holds FY profit guidance at 12%.

J+J earnings jump on higher sales

Third-quarter earnings lift 26 per cent despite stronger US dollar.

Cochlear reaffirms dividend optimism

Biotech company says dividend will return to high payout ratio, upbeat about sales momentum.

Biotron shares surge after potential Hep C cure

by AAP
Drug developer Biotron shares soar 75% after announcing it may have found a cure for hepatitis C.

Biotech chief took money for 'need, greed'

by AAP
Court hears Phosphagenics CEO stole around $6 million to fund lifestyle, daughter's healthcare.

ASIC slams life insurance 'failure'

ASIC investigation into life insurance advice found 37% of cases out of step with the law.

The amazing Sue Ismiel and her daughters

Remarkable entrepreneurship grew one ball of sticky green goo into a $40 million per year empire.

CSL sees new blood in Australia

1 comment
CSL knocked back offers from Switzerland, Germany and the US before deciding to build its new albumin plant in Melbourne.

CSL adds 390 jobs in $210m expansion

Biotherapy manufacturer CSL expands its Broadmeadows facility in $210m government partnership.

Coalition rejects Medibank ownership claims

Govt says Medibank Private float won't be disrupted by ownership claim from policyholders.

Regis debut to encourage rivals

Strong debut from Regis Healthcare may accelerate rivals' plans to float on the ASX.